Concepts (50)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 3 | 2024 | 84 | 1.140 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 155 | 0.900 |
Why?
|
| MicroRNAs | 2 | 2022 | 281 | 0.780 |
Why?
|
| Mouth Neoplasms | 1 | 2022 | 55 | 0.770 |
Why?
|
| Coumaric Acids | 2 | 2015 | 9 | 0.240 |
Why?
|
| Insulin | 2 | 2017 | 315 | 0.230 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 60 | 0.210 |
Why?
|
| Liver | 2 | 2015 | 424 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 325 | 0.190 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 377 | 0.170 |
Why?
|
| Fructose | 2 | 2015 | 22 | 0.150 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 106 | 0.140 |
Why?
|
| Plasticizers | 1 | 2017 | 4 | 0.140 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2017 | 6 | 0.140 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 134 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 50 | 0.140 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 62 | 0.130 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 96 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2017 | 1379 | 0.100 |
Why?
|
| Humans | 3 | 2024 | 27165 | 0.070 |
Why?
|
| Deoxyglucose | 2 | 2017 | 9 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2017 | 307 | 0.060 |
Why?
|
| Cell Death | 1 | 2024 | 111 | 0.050 |
Why?
|
| Cisplatin | 1 | 2024 | 175 | 0.050 |
Why?
|
| Rats | 2 | 2017 | 1554 | 0.050 |
Why?
|
| Cell Movement | 1 | 2022 | 353 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 446 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1406 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 775 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 738 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 1271 | 0.040 |
Why?
|
| Animals | 3 | 2017 | 10093 | 0.040 |
Why?
|
| Glycogen | 1 | 2017 | 21 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2017 | 236 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 589 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2015 | 1 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 1 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cholagogues and Choleretics | 1 | 2015 | 3 | 0.030 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 16 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 149 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 198 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 978 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 342 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 355 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 331 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2015 | 172 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 622 | 0.030 |
Why?
|
| Male | 2 | 2015 | 13041 | 0.020 |
Why?
|